Oct 31, 2018
This week's View explores initial two-drug pharmacotherapy for hypertension, antihypertensive therapy in adults with mild hypertension at low risk for cardiovascular disease, and transcatheter mitral valve replacement for patients with degenerated bioprostheses, failed annuloplasty rings, and severe mitral annular calcification.